CGEN Compugen Ltd.
Healthcare$2.65-5.36%ClosedMarket Cap: $250.6M
As of 2026-05-26
Valuation
P/E (TTM)
6.90
PEG
0.02
P/B
2.78
P/S
3.64
EV/EBITDA
7.49
DCF Value
$-12.46
FCF Yield
0.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
88.1%
Operating Margin
42.3%
Net Margin
48.0%
ROE
47.7%
ROA
23.9%
ROIC
24.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $2.2M | 16.2% | $-9.0M | $-7.7M | $— | — |
| Q4 null | $67.3M | 94.7% | $56.0M | $56.8M | $— | — |
| FY null | $72.8M | 87.3% | $31.3M | $35.3M | $— | — |
| Q3 null | $1.9M | 12.7% | $-7.9M | $-7.0M | $— | — |
| Q2 null | $1.3M | -32.5% | $-8.4M | $-7.3M | $— | — |
| Q1 null | $2.3M | -5.1% | $-8.4M | $-7.2M | $— | — |
| Q4 null | $1.5M | 54.1% | $-7.5M | $-6.1M | $— | — |
| FY null | $27.9M | 71.5% | $-14.9M | $-14.2M | $— | — |
| Q3 null | $17.1M | 79.0% | $4.5M | $1.3M | $— | — |
| Q2 null | $6.7M | 76.8% | $-3.4M | $-2.1M | $— | — |
| Q1 null | $2.6M | 17.9% | $-8.5M | $-7.3M | $— | — |
| Q4 2023 | $33.5M | 94.0% | $18.0M | $9.7M | $0.11 | — |